Biology subjects

Jespersen, S.

Publications and source records attributed to Jespersen, S..

3 recordsLinked to original sources

bioRxiv2024

Deuterium Metabolic Imaging Phenotypes Mouse Glioblastoma Heterogeneity Through Glucose Turnover Kinetics

Glioblastomas are aggressive brain tumors with dismal prognosis. One of the main bottlenecks for developing more effective therapies for glioblastoma stems from their histologic and molecular heterogeneity, leading to distinct tumor microenvironments and disease phenotypes. Effectively characterizing these features would improve the clinical management of glioblastoma. Glucose flux rates through glycolysis and mitochondrial oxidation have been recently shown to quantitatively depict glioblastoma proliferation in mouse models (GL261 and CT2A tumors) using dynamic glucose-enhanced (DGE) deuterium spectroscopy. However, the spatial features of tumor microenvironment phenotypes remain hitherto unresolved. Here, we develop a DGE Deuterium Metabolic Imaging (DMI) approach for profiling tumor microenvironments through glucose conversion kinetics. Using a multimodal combination of tumor mouse models, novel strategies for spectroscopic imaging and noise attenuation, and histopathological correlations, we show that tumor lactate turnover mirrors phenotype differences between GL261 and CT2A mouse glioblastoma, whereas recycling of the peritumoral glutamate-glutamine pool is a potential marker of invasion capacity in pooled cohorts, linked to secondary brain lesions. These findings were validated by histopathological characterization of each tumor, including cell density and proliferation, peritumoral invasion and distant migration, and immune cell infiltration. Our study bodes well for precision neuro-oncology, highlighting the importance of mapping glucose flux rates to better understand the metabolic heterogeneity of glioblastoma and its links to disease phenotypes.

cancer biology↗

bioRxiv2023

Efficient PCA denoising of spatially correlated MRI data

Mar[c]enko-Pastur (MP) PCA denoising is emerging as an effective means for noise suppression in MRI acquisitions with redundant dimensions. However, MP-PCA performance is severely compromised by spatially correlated noise - an issue typically affecting most modern MRI acquisitions - almost to the point of returning the original images with little or no noise removal. In this study, we develop and apply two new strategies that enable efficient and robust denoising even in the presence of severe spatial correlations. This is achieved by measuring a-priori information about the noise variance and combing these estimates with PCA denoising thresholding concepts. The two denoising strategies developed here are: 1) General PCA (GPCA) denoising that uses a-priori noise variance estimates without assuming specific noise distributions; and 2) Threshold PCA (TPCA) denoising which removes noise components with a threshold computed from a-priori estimated noise variance to determine the upper bound of the MP distribution. These strategies were tested in simulations with known ground truth and applied for denoising diffusion MRI data acquired using pre-clinical (16.4T) and clinical (3T) MRI scanners. In synthetic phantoms, MP-PCA failed to denoise spatially correlated data, while GPCA and TPCA correctly classified all signal/noise components. In cases where the noise variance was not accurately estimated (as can be the case in many practical scenarios), TPCA still provides excellent denoising performance. Our experiments in pre-clinical diffusion data with highly corrupted by spatial correlated noise revealed that both GPCA and TPCA robustly denoised the data while MP-PCA denoising failed. In in vivo diffusion MRI data acquired on a clinical scanner in healthy subjects, MP-PCA weakly removed noised, while TPCA was found to have the best performance, likely due to misestimations of the noise variance. Thus, our work shows that these novel denoising approaches can strongly benefit future pre-clinical and clinical MRI applications.

neuroscience↗

bioRxiv2021

Improving stroke detection via Correlation Tensor MRI

Noninvasively detecting and characterizing modulations in cellular scale micro-architecture is a desideratum for contemporary neuroimaging. Diffusion MRI (dMRI) has become the mainstay methodology for probing microstructure, and, in ischemia, its contrasts have revolutionized stroke management. However, the biological underpinnings of the contrasts observed in conventional dMRI in general and in ischemia in particular are still highly debated since the markers only indirectly reporter on microstructure. Here, we present Correlation Tensor MRI (CTI), a method that rather than measuring diffusion, harnesses diffusion correlations as its source of contrast. We show that CTI can resolve the sources of diffusional kurtosis, which in turn, provide dramatically enhanced specificity and sensitivity towards ischemia. In particular, the sensitivity towards ischemia nearly doubles, both in grey matter (GM) and white matter (WM), and unique signatures for neurite beading, cell swelling, and edema are inferred from CTI. The enhanced sensitivity and specificity endowed by CTI bodes well for future applications in biomedicine, basic neuroscience, and in the clinic.

neuroscience↗